SkyOak Wealt »

Neumora Therapeutics shares owned by SkyOak Wealt

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by SkyOak Wealt from 13F filings

Historical chart of SkyOak Wealt investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by SkyOak Wealt consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by SkyOak Wealt

Quarter filed Position value Share count Share price at filing
2024-09-30 $198k 15k 13.21
2024-06-30 $148k 15k 9.83

More positions owned by SkyOak Wealt

J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Core S&p Us Vlu (IUSV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Eli Lilly & Co. (LLY)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Scp Etf (IJR)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Technology (XLK)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Strategy Day Hagan Ned (SSUS)
Microsoft Corporation (MSFT)

View all positions for SkyOak Wealt

Top funds holding Neumora Therapeutics

Softbank Group Corp
BlackRock
T. Rowe Price Investment Management
BlackRock
MIC Capital Management UK
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Vanguard Group
Siren
EcoR1 Capital
Geode Capital Management
Johnson & Johnson
Avidity Partners Management
OrbiMed Advisors
State Street Corporation

View all funds holding Neumora Therapeutics